[HTML][HTML] Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and …
K Kaneko, CR Acharya, H Nagata, X Yang… - … for Immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background We previously demonstrated potent antitumor activity against human breast
cancer xenografts using photodynamic therapy (PDT) targeting a novel tumor-specific …
cancer xenografts using photodynamic therapy (PDT) targeting a novel tumor-specific …
[HTML][HTML] Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and …
K Kaneko, CR Acharya, H Nagata, X Yang… - … for ImmunoTherapy of …, 2022 - jitc.bmj.com
Background We previously demonstrated potent antitumor activity against human breast
cancer xenografts using photodynamic therapy (PDT) targeting a novel tumor-specific …
cancer xenografts using photodynamic therapy (PDT) targeting a novel tumor-specific …
Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal …
K Kaneko, CR Acharya, H Nagata, X Yang… - … for ImmunoTherapy of …, 2022 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background</jats: title>< jats: p> We previously demonstrated
potent antitumor activity against human breast cancer xenografts using photodynamic …
potent antitumor activity against human breast cancer xenografts using photodynamic …
Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal …
K Kaneko, CR Acharya, H Nagata… - Journal for …, 2022 - pubmed.ncbi.nlm.nih.gov
Background We previously demonstrated potent antitumor activity against human breast
cancer xenografts using photodynamic therapy (PDT) targeting a novel tumor-specific …
cancer xenografts using photodynamic therapy (PDT) targeting a novel tumor-specific …
Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal …
K Kaneko, CR Acharya, H Nagata, X Yang… - … for Immunotherapy of …, 2022 - europepmc.org
Background We previously demonstrated potent antitumor activity against human breast
cancer xenografts using photodynamic therapy (PDT) targeting a novel tumor-specific …
cancer xenografts using photodynamic therapy (PDT) targeting a novel tumor-specific …
Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal …
K Kaneko, CR Acharya, H Nagata… - Journal for …, 2022 - search.proquest.com
Background We previously demonstrated potent antitumor activity against human breast
cancer xenografts using photodynamic therapy (PDT) targeting a novel tumor-specific …
cancer xenografts using photodynamic therapy (PDT) targeting a novel tumor-specific …
Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal …
K Kaneko, CR Acharya, H Nagata, X Yang… - … for Immunotherapy of …, 2022 - europepmc.org
Background We previously demonstrated potent antitumor activity against human breast
cancer xenografts using photodynamic therapy (PDT) targeting a novel tumor-specific …
cancer xenografts using photodynamic therapy (PDT) targeting a novel tumor-specific …